Detection of Tumor Cells with Gd Probes
Journal of Medicinal Chemistry, 2006, Vol. 49, No. 16 4935
(23) Saris, S. C.; Solares, G. R.; Wazer, D. E.; Cano, G.; Kerley, S. E.;
Joyce, M. A.; Adelman, L. S.; Harling, O. K.; Madoc-Jones, H.;
Zamenhof, R. G. Boron neutron capture therapy for murine malignant
gliomas. Cancer Res. 1992, 52, 4672-4677.
(24) Barth, R. F.; Coderre, J. A.; Vicente, M. G.; Blue, T. E. Boron neutron
capture therapy of cancer: current status and future prospects. Clin.
Cancer Res. 2005, 11, 3987-4002.
Supporting Information Available: Elemental analysis results
for all target compounds and description of HPLC methods 1-3
used for the purification of intermediates and final products. This
material is available free of charge via the Internet at http://
pubs.acs.org.
(25) Luciani, A.; Olivier, J. C.; Clement, O.; Siauve, N.; Brillet, P. Y.;
Bessoud, B.; Gazeau, F.; Uchegbu, I. F.; Kahn, E.; Frija, G.; Cuenod,
C. A. Glucose-receptor MR imaging of tumors: study in mice with
PEGylated paramagnetic niosomes. Radiology 2004, 231, 135-142.
(26) Bode, B. P. Recent molecular advances in mammalian glutamine
transport. J. Nutr. 2001, 131, 2475S-2485S.
References
(1) Rinck, P. A. Magnetic Resonance in Medicine; Blackwell Scientific
Publications: Oxford, U.K., 1993.
(2) Merbach, A. E.; Toth, E. The Chemistry of Contrast Agents in Medical
Magnetic Resonance Imaging; John Wiley & Sons: Chichester, U.K.,
2001.
(27) Souba, W. W. Glutamine and cancer. Ann. Surg. 1993, 218, 715-
728.
(3) Aime, S.; Botta, M.; Terreno, E. Gd(III)-based contrast agents for
MRI. AdV. Inorg. Chem. 2005, 57, 173-237.
(28) Medina, M. A. Glutamine and cancer. J. Nutr. 2001, 131, 2539S-
(4) Caravan, P.; Ellison, J. J.; McCurry, T. J.; Lauffer, R. B. Gadolinium-
(III) chelates as MRI contrast agents: structure, dynamics and
applications. Chem. ReV. 1999, 99, 2293-2352.
2542S.
(29) Bode, B. P.; Kaminski, D. L.; Souba, W. W.; Li, A. P. Glutamine
transport in isolated human hepatocytes and transformed liver cells.
Hepatology 1995, 21, 511-520.
(30) Fischer, C. P.; Bode, B. P.; Souba, W. W. Adaptive alterations in
cellular metabolism with malignant transformation. Ann Surg. 1998,
227, 627-634.
(31) Medina, M. A.; Sanchez-Jimenez, F.; Marquez, J.; Rodriguez
Quesada, A.; Nunez de Castro, I. Relevance of glutamine metabolism
to tumor cell growth. Mol. Cell. Biochem. 1992, 113, 1-15.
(32) Sidoryk, M.; Matyja, E.; Dybel, A.; Zielinska, M.; Bogucki, J.;
Jaskolski, D. J.; Liberski, P. P. Kowalczyk, P.; Albrecht, J. Increased
expression of a glutamine transporter SNAT3 is a marker of malignant
gliomas. NeuroReport 2004, 15, 575-578.
(33) Boggio, K.; Nicoletti, G.; Di Carlo, E.; Cavallo, F.; Landuzzi, L.;
Melani, C.; Giovarelli, M.; Rossi, I.; Nanni, P.; De Giovanni, C.;
Bouchard, P.; Wolf, S.; Modesti, A.; Musiani, P.; Lollini, P. L.;
Colombo, M. P.; Forni, G. Interleukin 12-mediated prevention of
spontaneous mammary adenocarcinomas in two lines of Her-2/neu
transgenic mice. J. Exp. Med. 1998, 3, 188, 589-596.
(34) Lattuada, L.; Demattio, S.; Vincenzi, V.; Cabella, C.; Visigalli, M.;
Aime, S.; Barge, A.; Geninatti Crich, S.; Gianolio, E. Bioorg. Med.
Chem. Lett. 2006, 16(15), 4111-4. Epub 2006 May 18.
(35) Geninatti Crich, S.; Lanzardo, S.; Barge, A.; Esposito, G.; Tei, L.;
Forni, G.; Aime, S. Visualization through magnetic resonance
imaging of DNA internalized following “in vivo” electroporation.
Mol. Imaging 2005, 4, 7-17.
(36) Powell, D. H.; Ni Dhubhghaill, O. M.; Pubanz, D.; Helm, L.;
Lebedev, Y.; Schlaepfer, W.; Merbach, A. E. Structural and dynamic
parameters obtained from 17O NMR, EPR, and NMRD studies of
monomeric and dimeric Gd3+ complexes of interest in magnetic
resonance imaging: an integrated and theoretically self-consistent
approach. J. Am. Chem. Soc. 1996, 118, 9333-9346.
(37) Banci, L.; Bertini, I.; Luchinat, C. Nuclear and Electron Relaxation.
The Magnetic Nucleus-Unpaired Electron Coupling in Solution;
VCH: Weinheim, Germany, 1991.
(38) Korb, J. P.; Ahadi, M.; Zientara, G. P.; Freed, J. H. Dynamic effects
of pair correlation functions on spin relaxation by translational
diffusion in two-dimensional fluids. J. Chem. Phys. 1987, 86, 1125-
1130.
(39) Terreno, E.; Geninatti Crich, S.; Belfiore, S.; Biancone, L.; Cabella,
C.; Esposito, G.; Manazza, A. D.; Aime, S. Effect of the intracellular
localization of a Gd-based imaging probe on the relaxation enhace-
ment of water protons. Magn. Reson. Med. 2006, 55(3), 491-7.
(40) Sieber, F.; Sieber-Blum, M. Dye-mediated photosensitization of
murine neuroblastoma cells. Cancer Res. 1986, 46, 2072-2076.
(41) McGivan, J. D. Rat hepatoma cells express novel transport systems
for glutamine and glutamate in addition to those present in normal
rat hepatocytes. Biochem. J. 1998, 330, 255-260.
(42) Bode, B. P.; Fuchs, B. C.; Hurley, B. P.; Conroy, J. L.; Suetterlin, J.
E.; Tanabe, K. K.; Rhoads, D. B.; Abcouwer, S. F.; Souba, W. W.
Molecular and functional analysis of glutamine uptake in human
hepatoma and liver-derived cells. Am. J. Physiol.: Gastrointest. LiVer
Physiol. 2002, 283, G1062-G1073.
(43) Cabella, C.; Geninatti Crich, S.; Corpillo, D.; Barge, A.; Ghirelli,
C.; Bruno, E.; Lorusso, V.; Uggeri, F.; Aime, S. Cellular labeling
with Gd(III) chelates: only high thermodynamic stabilities prevent
the cells to act as “sponges” of Gd3+ ions. Contrast Media Mol.
Imaging 2006, 1, 23-29.
(44) Collins, C. L.; Wasa, M.; Souba, W. W.; Abcouwer, S. F.
Determinants of glutamine dependence and utilization by normal and
tumor-derived breast cell lines. J. Cell. Physiol. 1998, 176, 166-
178.
(5) Liu, S. The role of coordination chemistry in the development of
target-specific radiopharmaceuticals. Chem. Soc. ReV. 2004, 33, 445-
461.
(6) Fichna, J.; Janecka, A. Synthesis of target-specific radiolabeled
peptides for diagnostic imaging. Bioconjugate Chem. 2003, 14, 3-17.
(7) Weiner, R. E.; Thakur, M. L. Radiolabeled peptides in the diagnosis
and therapy of oncological diseases. Appl. Radiat. Isot. 2002, 57,
749-763.
(8) Nunn, A. D.; Linder, K. E.; Tweedle, M. F. Can receptors be imaged
with MRI agents?. Q. J. Nucl. Med. 1997, 41, 155-162.
(9) Aime, S.; Cabella, C.; Colombatto, S.; Geninatti Crich, S.; Gianolio,
E.; Maggioni, F. Insights into the use of paramagnetic Gd(III)
complexes in MR-molecular imaging investigations. J. Magn. Reson.
Imaging 2002, 16, 394-406.
(10) Schmieder, A. H.; Winter, P. M.; Caruthers, S. D.; Harris, T. D.;
Williams, T. A.; Allen, J. S.; Lacy, E. K.; Zhang, H.; Scott, M. J.;
Hu, G.; Robertson, J. D.; Wickline, S. A.; Lanza, G. M. Molecular
MR imaging of melanoma angiogenesis with alphavbeta3-targeted
paramagnetic nanoparticles. Magn. Reson. Med. 2005, 53, 621-627.
(11) Winter, P. M.; Caruthers, S. D.; Kassner, A.; Harris, T. D.; Chinen,
L. K.; Allen, J. S.; Lacy, E. K.; Zhang, H.; Robertson, J. D.; Wickline,
S. A.; Lanza, G. M. Molecular imaging of angiogenesis in nascent
Vx-2 rabbit tumors using a novel alphavbeta3-targeted nanoparticle
and 1.5 T magnetic resonance imaging. Cancer Res. 2003, 63, 5838-
5843.
(12) Anderson, S. A.; Rader, R. K.; Westlin, W. F.; Null, C.; Jackson,
D.; Lanza, G. M.; Wickline, S. A.; Kotyk, J. J. Magnetic resonance
contrast enhancement of neovasculature with alpha(v)beta(3)-targeted
nanoparticles. Magn Reson Med. 2000, 44, 433-439.
(13) Sipkins, D. A.; Cheresh, D. A.; Kazemi, M. R.; Nevin, L. M.;
Bednarski, M. D.; Li, K. C. Detection of tumor angiogenesis in vivo
by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998,
4, 623-626.
(14) Funovics, M. A.; Kapeller, B.; Hoeller, C.; Su, H. S.; Kunstfeld, R.;
Puig, S.; Macfelda, K. MR imaging of the her2/neu and 9.2.27 tumor
antigens using immunospecific contrast agents. Magn. Reson. Imaging
2004, 22, 843-850.
(15) Artemov, D.; Mori, N.; Okollie, B.; Bhujwalla, Z. M. MR molecular
imaging of the Her-2/neu receptor in breast cancer cells using targeted
iron oxide nanoparticles. Magn. Reson. Med. 2003, 49, 403-408.
(16) Artemov, D.; Mori, N.; Ravi, R.; Bhujwalla, Z. M. Magnetic
resonance molecular imaging of the HER-2/neu receptor. Cancer Res.
2003, 63, 2723-2727.
(17) Mulder, W. J.; Strijkers, G. J.; Griffioen, A. W.; van Bloois, L.;
Molema, G.; Storm, G.; Koning, G. A.; Nicolay, K. A liposomal
system for contrast-enhanced magnetic resonance imaging of mo-
lecular targets. Bioconjugate Chem. 2004, 15, 799-806.
(18) Warburg, O. On the origin of cancer cells. Science 1956, 123, 309-
314.
(19) Couturier, O.; Luxen, A.; Chatal, J. F.; Vuillez, J. P.; Rigo, P.;
Hustinx, R. Fluorinated tracers for imaging cancer with positron
emission tomography. Eur. J. Nucl. Med. Mol. Imaging 2004, 31,
1182-1206.
(20) Kubota, K. From tumor biology to clinical Pet: a review of positron
emission tomography (PET) in oncology. Ann. Nucl. Med. 2001, 15,
471-486.
(21) Samnick, S.; Schaefer, A.; Siebert, S.; Richter, S.; Vollmar, B.;
Kirsch, C. M. Preparation and investigation of tumor affinity, uptake
kinetic and transport mechanism of iodine-123-labelled amino acid
derivatives in human pancreatic carcinoma and glioblastoma cells.
Nucl. Med. Biol. 2001, 28, 13-23.
(22) Conti, P. S. Introduction to imaging brain tumor metabolism with
positron emission tomography (PET). Cancer InVest. 1995, 13, 244-
259.
(45) Wasa, M.; Wang, H. S.; Okada, A. Characterization of L-glutamine
transport by a human neuroblastoma cell line. Am. J. Physiol.: Cell
Physiol. 2002, 282, C1246-C1253.